27 May 2025 : Original article
Impact of Preoperative Treatment on Donor Hepatic Steatosis in Living Donor Liver Transplantation
Ahmet Atasever
ABCEF 1, Sinan Efe Yazıcı ABEF 1*, Tolga Şahin ABCF 1, Yıldıray Yuzer A 2
DOI: 10.12659/AOT.947772
Ann Transplant 2025; 30:e947772
Table 5 Liver volumes.
| Patients receiving fatty liver treatment (n: 14) (mean±SD) | Patients with treatment non-compliance (n: 3) (mean±SD) | Patients not receiving fatty liver treatment (n: 20) (mean±SD) | |
|---|---|---|---|
| Total liver volume (gr) | 1447±458 | 2052±303 | 1231±162 |
| Right lobe volume (gr) | 985±332 | 1229±254 | 806±101 |
| Right lobe volume ratio (%) | 63±5 | 63±4 | 65±4 |
| Left lobe volume (gr) | 532±154 | 705±105 | 440±88 |
| Left lobe volume ratio (%) | 37±5 | 37±4 | 35±4 |
| Remnant liver volume/donor body weight (%) | 0.57±0.25 | 0.76±0.13 | 0.58±0.12 |
| Extracted graft volume/calculated volume (%) | 0.96±0.06 | – | 0.97±0.09 |
| Extracted graft weight (gr) | 844±225 | – | 781±100 |